More articles from Review Article

You have access
Cellular senescence: from mechanisms to current biomarkers and senotherapies
Vasco Lucas, Cláudia Cavadas and Célia Alexandra Aveleira

Pharmacological Reviews February 2, 2023, PHARMREV-AR-2022-000622; DOI: https://doi.org/10.1124/pharmrev.122.000622
You have access
ADVANCES IN NANOZYMES AS A PARADIGM FOR VIRAL DIAGNOSTICS AND THERAPY
Garima Sharma, Srijan Chatterjee, Chiranjib Chakraborty and Jin-Chul Kim

Pharmacological Reviews January 27, 2023, PHARMREV-AR-2022-000719; DOI: https://doi.org/10.1124/pharmrev.122.000719
You have access
Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction
Qiang Ma

Pharmacological Reviews January 20, 2023, PHARMREV-AR-2022-000629; DOI: https://doi.org/10.1124/pharmrev.122.000629
You have access
Understanding the neural mechanisms of general anesthesia from interaction with sleep-wake state: a decade of discovery
Wei-Wei Bao, Shan Jiang, Wei-Min Qu, Wen-Xian Li, Chang-Hong Miao and Zhi-Li Huang

Pharmacological Reviews January 10, 2023, PHARMREV-AR-2022-000717; DOI: https://doi.org/10.1124/pharmrev.122.000717
You have access
Time to change: A systems pharmacology approach to disentangle mechanisms of drug-induced mitochondrial toxicity
Charlotte A. Hoogstraten, Jonathan J. Lyon, Jan A.M. Smeitink, Frans G.M. Russel and Tom J.J. Schirris

Pharmacological Reviews January 10, 2023, PHARMREV-AR-2022-000568; DOI: https://doi.org/10.1124/pharmrev.122.000568
You have access
Turn on, tune in, turnover! Target biology impacts in vivo potency, efficacy, and clearance
Johan Gabrielsson and Stephan Hjorth

Pharmacological Reviews January 10, 2023, PHARMREV-AR-2021-000524; DOI: https://doi.org/10.1124/pharmrev.121.000524
Open Access
Dopamine, Immunity, and Disease
Breana Channer, Stephanie M. Matt, Emily A. Nickoloff-Bybel, Vasiliki Pappa, Yash Agarwal, Jason Wickman and Peter J. Gaskill
Habibeh Khoshbouei, ASSOCIATE EDITOR

Pharmacological Reviews January 2023, 75 (1) 62-158; DOI: https://doi.org/10.1124/pharmrev.122.000618
You have access
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer
Al-Hassan M. Mustafa and Oliver H. Krämer
Lynette Daws, ASSOCIATE EDITOR

Pharmacological Reviews January 2023, 75 (1) 35-61; DOI: https://doi.org/10.1124/pharmrev.122.000612
Open Access
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
Ilana B. Kotliar, Emily Lorenzen, Jochen M. Schwenk, Debbie L. Hay and Thomas P. Sakmar
Gunnar Schulte, ASSOCIATE EDITOR

Pharmacological Reviews January 2023, 75 (1) 1-34; DOI: https://doi.org/10.1124/pharmrev.120.000180
Open Access
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
Péter Ferdinandy, Ioanna Andreadou, Gary F. Baxter, Hans Erik Bøtker, Sean M. Davidson, Dobromir Dobrev, Bernard J. Gersh, Gerd Heusch, Sandrine Lecour, Marisol Ruiz-Meana, Coert J. Zuurbier, Derek J. Hausenloy and Rainer Schulz
Finn Olav Levy, ASSOCIATE EDITOR

Pharmacological Reviews January 2023, 75 (1) 159-216; DOI: https://doi.org/10.1124/pharmrev.121.000348

Main menu

User menu

Search

More articles from Review Article

Pages

Navigate

More Information

ASPET's Other Journals